In order to overcome this issue, we hypothesize that a Lf-bearing DAB dendrimer complexed to plasmid DNA encoding TNFα, TRAIL, and IL-12 would enhance the delivery of therapeutic DNA to prostate tumors and increase its therapeutic efficacy in vitro as well as in vivo. This evidence concerns the gene TNF and prostate neoplasm.